This is in line with a previous report from a T cell lymphoma mouse model where PD-1 activity enhanced PTEN levels, and PD-1 deletion after an oncogenic insult resulted in aggressive lymphomas in vivo [94]. This evidence concerns the gene PDCD1 and T-cell non-Hodgkin lymphoma.